Company Description
Blue Owl Capital Inc. operates as an asset manager in the United States.
The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants.
It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.
It offers its solutions through permanent capital vehicles, as well as long-dated private funds. Blue Owl Capital Inc. is headquartered in New York, New York.
Country | United States |
Founded | 2020 |
Industry | Asset Management |
Sector | Financials |
Employees | 685 |
CEO | Douglas Irving Ostrover |
Contact Details
Address: 399 Park Avenue, 37th Floor New York, New York 10022 United States | |
Phone | 212 419 3000 |
Website | blueowl.com |
Stock Details
Ticker Symbol | OWL |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001823945 |
CUSIP Number | 09581B103 |
ISIN Number | US09581B1035 |
Employer ID | 86-3906032 |
SIC Code | 6282 |
Key Executives
Name | Position |
---|---|
Marc S. Lipschultz | Co-Founder, Co-Chief Executive Officer and Director |
Douglas Irving Ostrover | Co-Founder, Chairman and Co-Chief Executive Officer |
Michael Douglass Rees | Co-Founder, Co-President, Head of Blue Owl's Dyal Capital Division and Director |
Craig William Packer | Head of Credit, Co-Founder, Co-President, Senior MD and Director |
Marc Zahr | Co-President and Director |
Alan Jay Kirshenbaum CPA, CPA | Chief Financial Officer |
Sean Ward J.D. | Senior MD and Director |
Andrew Robert Polland | Chief Operating Officer |
Ann Dai | MD and Head of Investor Relations |
Chris Eby | Head of Strategy and Corporate Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 6, 2024 | 144 | Filing |
Nov 6, 2024 | 10-Q | Quarterly Report |
Oct 31, 2024 | 8-K | Current Report |
Oct 7, 2024 | 8-K | Current Report |
Sep 30, 2024 | 8-K/A | [Amend] Current report |
Sep 25, 2024 | EFFECT | Notice of Effectiveness |